Serena Ruggieri

Pubblicazioni

Titolo Pubblicato in Anno
CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis CELLS 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study JOURNAL OF NEUROLOGY 2019
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients CELLS 2019
Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis JOURNAL OF NEUROPSYCHOLOGY 2019
A matter of atrophy: differential impact of brain and spine volume loss on disability worsening in MS onlinelibrary.ectrims-congress.euMULTIPLE SCLEROSIS 2019
Tumefactive Demyelinating Lesions and Pregnancy NEUROLOGY INDIA 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction HAEMATOLOGICA 2019
Lifespan normative data on rates of brain volume changes NEUROBIOLOGY OF AGING 2019
Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Advances in spinal cord imaging in multiple sclerosis THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 2019
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis JOURNAL OF NEUROLOGY 2019
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: Implication in peripheral inflammation SCIENTIFIC REPORTS 2018
Listeria monocytogenes-Induced rhombencephalitis in a patient with multiple sclerosis treated with dimethyl fumarate JAMA NEUROLOGY 2018
Progression of regional grey matter atrophy in multiple sclerosis BRAIN 2018
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis SCIENTIFIC REPORTS 2018
Deep gray matter volume loss drives disability worsening in multiple sclerosis ANNALS OF NEUROLOGY 2018
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study LANCET NEUROLOGY 2018
Lesion symptom map of cognitive–postural interference in multiple sclerosis MULTIPLE SCLEROSIS 2018
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study NEUROLOGY 2018
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study JOURNAL OF NEUROLOGY 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma